Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Safety, Tolerability, and Efficacy of Shorter Infusion Durations of Pegloticase Administered to Patients With Uncontrolled Gout Receiving Methotrexate: AGILE Trial.
Journal: Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases
Published: September 23, 2025
Treatment-emergent major adverse cardiovascular and thromboembolic events were infrequent during clinical trials of pegloticase.
Journal: Rheumatology (Oxford, England)
Published: November 15, 2024
Pegloticase and Methotrexate Cotherapy in Patients With Uncontrolled Gout With Prior Pegloticase Monotherapy Failure: Findings of an Open-Label Trial.
Journal: ACR open rheumatology
Published: August 19, 2024
Very early MRI responses to therapy as a predictor of later radiographic progression in early rheumatoid arthritis.
Journal: Arthritis research & therapy
Published: May 01, 2019
Characterization of patients with chronic refractory gout who do and do not have clinically apparent tophi and their response to pegloticase.
Journal: Rheumatology (Oxford, England)
Published: August 20, 2018
Short-term changes on MRI predict long-term changes on radiography in rheumatoid arthritis: an analysis by an OMERACT Task Force of pooled data from four randomised controlled trials.
Journal: Annals of the rheumatic diseases
Published: August 03, 2016
Proceedings from The 8th Annual International Society for Musculoskeletal Imaging in Rheumatology (ISEMIR) Conference.
Journal: Seminars in arthritis and rheumatism
Published: July 28, 2015
Examining the validity of the rheumatoid arthritis magnetic resonance imaging score according to the OMERACT filter-a systematic literature review.
Journal: Rheumatology (Oxford, England)
Published: April 22, 2015
Proceedings from the 7th Annual International Society for Musculoskeletal Imaging in Rheumatology (ISEMIR) conference.
Journal: Seminars in arthritis and rheumatism
Published: January 12, 2015
Clinical and radiographic outcomes at 2 years and the effect of tocilizumab discontinuation following sustained remission in the second and third year of the ACT-RAY study.
Journal: Annals of the rheumatic diseases
Published: August 30, 2014
Last Updated: 09/26/2026